AYR WELLNESS INC - AYRWF STOCK NEWS

Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) announced the launch of its premium whole flower brand, Kynd, in Pennsylvania, along with the opening of its ninth medical dispensary in Indiana on July 30, 2022. The Kynd brand includes five strains and is now available in all nine affiliated stores in Pennsylvania as well as in other states such as Massachusetts and Nevada, where it leads in sales. The new Indiana dispensary will offer a variety of cannabis products including flower, vaporizers, and tinctures, serving the local community's medical needs.

Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) announced the opening of its 49th Florida dispensary in Clearwater. The new location features over 6,100 sq. ft. of retail space and offers a range of products, including concentrates, edibles, vapes, and premium flower. Following the 2021 acquisition of Liberty Health Sciences, Ayr has expanded significantly, now operating 49 stores in Florida. The state's medical marijuana program has over 738,000 enrolled patients, with the market projected to reach $3.4 billion annually by 2026.

Ayr Wellness Inc (OTCQX: AYRWF), a prominent U.S. multi-state cannabis operator, is set to hold a conference call on August 18, 2022, at 8:30 a.m. ET, to discuss its Q2 financial results ending June 30, 2022. CEO Jonathan Sandelman, Co-COO Jennifer Drake, and CFO Brad Asher will lead the call, which includes a Q&A session. A press release with detailed financial results will precede the call. Interested parties can access the call via a toll-free number or through a webcast link provided in the announcement.

Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) has opened its second adult-use cannabis dispensary in the Greater Boston area, located in Watertown, effective July 12, 2022. The new store offers a variety of cannabis products and aims to serve both experienced users and newcomers. Ayr's CEO, Jonathan Sandelman, expressed enthusiasm for this expansion, coinciding with a grand opening celebration for their Back Bay location. Medical cannabis sales at the Watertown site are pending approval from the Massachusetts Cannabis Control Commission.

Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) announced the opening of its flagship dispensary, AYR in Back Bay, Boston, on July 2, 2022. This location marks Ayr's first adult-use retail sales in Massachusetts. Situated at 827 Boylston St., near major attractions like the Apple Store, it aims to benefit from high foot traffic. Ayr offers a variety of cannabis products, including its Kynd premium flower and Wicked edibles. The company also received a license to open a second dispensary in Watertown, planned for July 2022.

Ayr Wellness Inc. (OTCQX: AYRWF) has opened its 48th Florida dispensary in Longwood, expanding its retail presence in the state. The new 2,300+ sq. ft. facility features a drive-thru and offers a full range of products, including concentrates, edibles, and premium flower. Since acquiring Liberty Health Sciences in 2021, Ayr has launched 17 new stores in Florida. The state boasts approximately 730,000 medical marijuana patients and generated over $1.8 billion in cannabis revenue in 2021, with projections reaching $3.4 billion annually by 2026.

Ayr Wellness Inc. (OTCQX: AYRWF) announced the opening of three adult-use cannabis dispensaries in New Jersey on June 15, 2022. Located in Woodbridge, Union, and Eatontown, these stores are part of Ayr’s strategy to expand its retail presence in a densely populated region of 3.4 million people. The company aims to capture market share, as adult-use sales in New Jersey reached $24 million in the first month. Ayr operates these dispensaries under the Garden State Dispensary brand and is positioned to benefit from the overall projected growth in legal cannabis sales, estimated to reach $2.3 billion annually by 2026.

Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) has received a final license from the Massachusetts Cannabis Control Commission to sell adult-use cannabis at its Watertown dispensary in Greater Boston, approved on June 9, 2022. This license allows Ayr to operate two adult-use dispensaries in the area, enhancing cannabis access in a historically underserved market. Ayr aims to provide high-quality products and a unique customer experience, while also engaging positively with the Watertown community. The company is committed to further regulatory approvals for additional locations in Greater Boston.

Ayr Wellness reported Q1 2022 revenue of $111.2 million, a 90% increase year-over-year. Adjusted EBITDA rose 6% to $19.5 million. However, the company faced a US GAAP operating loss of $21.1 million, compared to $8.4 million in Q1 2021. Ayr received final approval for adult-use cannabis sales in New Jersey and Boston, expected to launch in June. The company aims for a run-rate of $250 million adjusted EBITDA by Q4 2022, backed by recent investments and acquisitions.